CFB Antibody, FITC conjugated (PACO32950)
- SKU:
- PACO32950
- Product type:
- Antibody
- Reactivity:
- Human
- Host Species:
- Rabbit
- Isotype:
- IgG
- Application:
- ELISA
- Antibody type:
- Polyclonal
- Conjugation:
- FITC
Frequently bought together:
Description
抗体名: | CFB Antibody, FITC conjugated (PACO32950) |
抗体コード: | PACO32950 |
サイズ: | 50ug |
宿主種: | Rabbit |
申し込み: | ELISA |
推奨される希釈: | |
反応性: | Human |
免疫原: | Recombinant Human Complement factor B protein (26-751AA) |
憲法: | Liquid |
ストレージバッファ: | Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 |
精製方法: | >95%, Protein G purified |
抗体のクローン性: | Polyclonal |
アイソタイプ: | IgG |
Conjugate: | FITC |
バックグラウンド: | Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B-lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes. |
シノニム: | Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich β glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment], CFB, BF BFD |
UniProt Protein Function: | CFB: Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B- lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes. Defects in CFB are a cause of susceptibility to hemolytic uremic syndrome atypical type 4 (AHUS4). An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. Susceptibility to the development of atypical hemolytic uremic syndrome can be conferred by mutations in various components of or regulatory factors in the complement cascade system. Other genes may play a role in modifying the phenotype. Belongs to the peptidase S1 family. 2 isoforms of the human protein are produced by alternative splicing. |
UniProt Protein Details: | Protein type:Protease; Secreted, signal peptide; EC 3.4.21.47; Secreted Chromosomal Location of Human Ortholog: 6p21.3 Cellular Component: extracellular region; extracellular space; plasma membrane Molecular Function:complement binding; serine-type endopeptidase activity Biological Process: complement activation; complement activation, alternative pathway; regulation of complement activation Disease: Complement Factor B Deficiency; Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 4; Macular Degeneration, Age-related, 14 |
NCBI Summary: | This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. [provided by RefSeq, Jul 2008] |
UniProt Code: | P00751 |
NCBI GenInfo Identifier: | 584908 |
NCBI Gene ID: | 629 |
NCBI Accession: | P00751.2 |
UniProt Secondary Accession: | P00751,O15006, Q29944, Q53F89, Q5JP67, Q5ST50, Q96HX6 Q9BTF5, Q9BX92, B0QZQ6, |
UniProt Related Accession: | P00751 |
Molecular Weight: | 68,872 Da |
NCBI Full Name: | Complement factor B |
NCBI Synonym Full Names: | complement factor B |
NCBI Official Symbol: | CFB |
NCBI Official Synonym Symbols: | BF; FB; BFD; GBG; CFAB; CFBD; PBF2; AHUS4; FBI12; H2-Bf; ARMD14 |
NCBI Protein Information: | complement factor B |
UniProt Protein Name: | Complement factor B |
UniProt Synonym Protein Names: | C3/C5 convertase; Glycine-rich beta glycoprotein; GBG |
Protein Family: | Complement factor |
UniProt Gene Name: | CFB |
UniProt Entry Name: | CFAB_HUMAN |